fbpx

Press Releases

NextCell Pharma AB comments on the trading halt of 25 April 2019

With respect to Spotlight Stock Market’s decision on 25 April 2019 to halt trading in NextCell Pharma AB’s share, the stock market has, in accordance with its regulations, ordered the…

Cellaviva Sverige April 26, 2019

NextCell's biobank Cellaviva has received permission from IVO to handle stem cells from adipose tissue

NextCell Pharma AB (“NextCell”) announces today that its biobank Cellaviva has been granted an extended permit from the Health and Care Inspectorate (IVO), to also handle and store stem cells…

Cellaviva Sverige April 5, 2019

NextCell and Cellaviva are highlighted by KI Innovations

The stem cell company NextCell Pharma (“NXTCL”) announces that the company and its stem cell bank Cellaviva are highlighted by Karolinska Institutet Innovations as a positive example in its Jubilee…

Cellaviva Sverige March 29, 2019

NextCell continuous to strengthen development and collaborative activities

NextCell Pharma AB (“NextCell”) announces today, that during the last few months the company has engaged in an array of valuable activities and collaborations. NextCell is active in the “SweLife…

Cellaviva Sverige March 22, 2019

NextCell continues to develop

NextCell Pharma AB (“NextCell”) gives the market updated information before its presentation at ProHearing later today by CEO, Mathias Svahn. Recruitment of patients with type-1 diabetes in the Phase II…

Cellaviva Sverige February 22, 2019

NextCell listed on the Life Science Hotlist

NextCell Pharma AB (“NXTCL”) announces that Invest Stockholm has now placed NXTCL on the Life Science Hotlist. The Stockholm-Uppsala Life Science Investment Hotlist is curated by Invest Stockholm and lists…

Cellaviva Sverige February 12, 2019

NextCell´s CEO invited speaker at National conference on Clinical Studies

NextCell Pharma AB (“NXTCL”) announces that its CEO, Mathias Svahn PhD has been invited to speak at the 2019 National Conference on Clinical Studies. The conference, which is held in…

Cellaviva Sverige February 7, 2019

Saving of stem cell from births increases significantly for NextCell´s biobank Cellaviva

Stem cell company NextCell Pharma AB (”NXTCL”) announces that Cellaviva’s sales has increased significantly from November 2018 to January 2019, as compared to the corresponding months previous year. It is…

Cellaviva Sverige February 5, 2019

Iterim report quarter 1

First quarter (2018-09-01 till 2018-11-30) Net sales amounted to SEK 73,745 (158,354). Apart from the accrual effect, sales increased by 7 %. Operating result amounted to SEK -5,440,809 (-3,210,815).                         Earnings…

Cellaviva Sverige January 31, 2019

Patients treated with ProTrans in phase II of the clinical trial

NextCell Pharma AB (“NextCell”) hereby announces that they today have reached a significant milestone as they have now initiated the second part of the ProTrans-1 clinical trial. In addition to…

Cellaviva Sverige January 30, 2019

NextCell strengthens the organization for continued growth

NextCell Pharma AB (“NextCell”) hereby announces that the Board has decided to appoint Sofia Fredrikson to CFO in the company. Sofia Fredrikson will take office starting today. Former CFO, Leo…

Cellaviva Sverige December 5, 2018

NextCell CEO invited speaker at Karolinska Institutet Conference

NextCell Pharma AB (“NXTCL”) announces that its CEO, Mathias Svahn PhD has been invited to speak at the Karolinska Institutet conference “From tissue to motion” – a 10-year anniversary. The…

Cellaviva Sverige November 28, 2018